Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deciphera Pharmaceuticals (DCPH)
NASDAQ:DCPH
RESEARCH TOOLSreports
Holding DCPH?
Track your performance easily
See the Price Targets and Ratings of:
DCPH Analyst Ratings
Hold
0 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DCPH Stock 12 Month Forecast
Average Price Target
$24.40
▼(-4.65% Downside)
| Highest Price Target$26.00 | Average Price Target$24.40 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Downgraded
05/14/24
JMP Securities
Reiterated
05/13/24
Leerink Partners
Reiterated
05/10/24
Barclays
Assigned
05/06/24
Guggenheim
Downgraded
04/29/24
Piper Sandler
Downgraded
04/29/24
Jefferies
Downgraded
04/29/24
J.P. Morgan
Reiterated
03/20/24
H.C. Wainwright
$30
Buy
17.23%
Upside
Reiterated
02/07/24
Wall Street Analysts Are Bullish on Top Healthcare Picks
TD Cowen
$30
Buy
17.23%
Upside
Reiterated
02/06/24
Deciphera Pharmaceuticals: Sustained Growth and Market Expansion Drive Buy Rating
Best Analysts Covering Deciphera Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy DCPH and Sell After:
1 Month
xxx
Success Rate
4/9 ratings generated profit
Average Return
-1.23%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of -1.23% per trade.
3 Months
xxx
Success Rate
3/9 ratings generated profit
Average Return
+1.87%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of +1.87% per trade.
1 Year
Success Rate
4/9 ratings generated profit
Average Return
+27.39%
reiterated a buy rating 10 months ago
Copying Andrew Fein's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of +27.39% per trade.
2 Years
xxx
Success Rate
9/9 ratings generated profit
Average Return
+65.34%
reiterated a xxx
rating 10 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +65.34% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
DCPH Analyst Recommendation Trends
Rating
Jan 24
Feb 24
Mar 24
Apr 24
May 24
Strong Buy
8
8
7
7
2
Buy
4
3
3
1
0
Hold
2
1
1
8
13
Sell
0
2
2
2
0
Strong Sell
0
0
0
0
0
total
14
14
13
18
15
Each month's total comprises the sum of three months' worth of ratings.
DCPH Financial Forecast
DCPH Stock Forecast FAQ
What is DCPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Deciphera Pharmaceuticals’s 12-month average price target is $24.40.
What is DCPH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DCPH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DCPH a Buy, Sell or Hold?
Deciphera Pharmaceuticals has a consensus rating of Hold which is based on 0 buy ratings, 8 hold ratings and 0 sell ratings.
What is Deciphera Pharmaceuticals’s price target?
The average price target for Deciphera Pharmaceuticals is $24.40. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $26.00 ,the lowest forecast is $16.00. The average price target represents -4.65% Decrease from the current price of $25.59.
The highest analyst price target is $26.00 ,the lowest forecast is $16.00. The average price target represents -4.65% Decrease from the current price of $25.59.
What do analysts say about Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of DCPH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.